Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Evolocumab (AMG 145) in Adults With Hyperlipidemia on Stable Doses of a Statin
Clinical trial NCT01133522 · COMPLETED
Trial details
- NCT number
- NCT01133522
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2011-09-14
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.